FIRST ROUND LEAD INVESTORS FOR CAPITAL-EFFICIENT ENTREPRENEURS

Activated Companies

Medication risk management solutions for health plans and providers.

Software that automates small group health plan sales, enrollment and renewals for the insurance industry.

Cloud-based solutions for clinical research.

Go-to-Market intelligence software for growth stage B2B companies.

Human capital management reference checking and credentialing software.

Biometric identity management and access technology solutions.

SaaS solution that helps health plans and self-insured employers obtain better care at a lower cost.

Clinical data quality and interoperability software.

Advanced quality management software for manufacturers and their suppliers.

E-commerce service for flexible spending accounts (FSAs) and health savings accounts (HSAs).

Competitive intelligence analytics software and content for R&D professionals.

Healthcare analytics and provider engagement software for risk-bearing providers.

Decades of experience and a far-reaching network of contacts

12 successful IPOs

40+ profitable exits to strategic and financial buyers

150+ technology-enabled companies financed

50 companies in healthcare

100+ companies financed as lead/co-lead investor

75% of capital invested in the Mid-Atlantic region

$10+ billion in market value attained upon exit

mostly pre-revenue companies at time of first investment

1st institutional investor in 85% of portfolio companies

50%+ of companies financed pre-revenue at time of first investment

CEO and Founder Testimonials

Brian Adams

Tabula Rasa

Activate helped us grow from a startup to a $1 billion public company. We could never have done it without them.

Matt Ranauro

Benefix

Activate isn’t just our lead VC, they are our partner. From the beginning, the amazing thing was, unlike the other firms we met with, the Activate team totally got our vision.

Tarek Sherif

Medidata

Activate’s partners led our first round of financing and were essential partners through to our successful IPO. We could not have found a better early stage investor.

Scott Stouffer

scaleMatters

When I started my first company, Visual Networks, Activate recognized the opportunity when others didn’t. Our IPO was a huge success. They were my first call to lead our seed round for scaleMatters.

Ray Bixler

SkillSurvey

I really valued Activate’s contribution to our board based on their decades of experience, their patience, their enthusiasm, extensive network and straightforward approach.

Bobby Varma

Princeton Identity

Activate is different than other venture firms. They have been constructive, responsive and most important, supportive. They are invaluable to have available but unobtrusive. Truly a first-class investor.

Kyle Raffaniello

Sapphire

Like most businesses, we had to overcome more than a few challenges. Activate supported us with the capital and strategic advice we needed to achieve a remarkable exit.

Eric Rosow

Diameter Health

Activate is founder-focused in a way most venture firms are not; they understand the importance of vision and culture. That is why we have joined forces twice.

Sam Golan

HighQA

Activate is unique because of their investment approach. You let them know when you want their help and they will make themselves available, versus trying to micro-manage their investment.

Jeremy Miller

FSA Store

Activate’s experience with early-stage companies has enabled them to be an effective partner. We created a trusting relationship, something that is rare in the venture capital business.

Steve Hafif

Cypris

Activate has been of enormous help in building our company and making introductions that enabled us to raise follow on financing from other like-minded investors. They are supportive and fair – a real class act.

Kevin Agatstein

KAID Health

I could not imagine a better partner for our early-stage healthcare company than Activate. They bring us a rare combination of deep industry connections, market insight and entrepreneurial zeal.

Investment Focus

Visionary founders with domain knowledge and the ability to scale a business operationally

Markets that are at an inflection point in demand where new approaches can create significant value and upset the status quo

Seed and early-stage companies where our decades-long track record of experience as a lead investor adds value in a company’s first institutional equity financing

Capital efficient businesses where first round financings of $5 million or less can create significant progress toward achieving business objectives

Meet our team

Glen Bressner

Co-Founder and Managing Partner

Todd Pietri

Co-Founder and Managing Partner

Don Yount

General Partner and Chief Financial Officer

Jarred Bressner, MD

Principal

Avlyn Ashterman-Reece

Administrative Director

Ed Goodman

Venture Partner

Jeff Davison

Venture Partner

News

Cypris Secures $5.3M in Venture Funding

July, 23, 2024

This funding will accelerate the scaling of Cypris’ AI-powered platform.

KAID Health and Park Medical Announce Strategic Partnership to Enhance Coding Accuracy, Efficiency and Care Quality

July, 16, 2024

KAID’s Artificial Intelligence (AI) and medical coders are supporting Park clinicians in better delivering high-quality care.

Princeton Identity Launches Multimodal Biometric Scanner to North American Market

March, 04, 2024

The new EyeAllow scanner supports face and iris biometrics, plus RFID cards, high-frequency smartcards, mobile credentials, on-card

Unite Us and Ride Health Partner to Improve Access to Transportation Services for New Yorkers

February, 15, 2024

The partnership between Unite Us and Ride Health reinforces transportation’s critical role as a key driver of

KAID Health Technology Demonstrates the Value of Natural Language Processing to Improve Preoperative Care

April, 24, 2023

We have demonstrated that NLP technology can help identify critical medical conditions relevant to pre-anesthetic evaluation.

Symphonic Partners With Bonsai to Better Monetize Fan Engagement

April, 20, 2023

The independent distributor will offer its artists early access to Bonsai’s fan monetization tools.

Subscribe to
our newsletter

Contact us

Pennsylvania Office

116 Research Drive
Bethlehem, PA 18015
Phone (610) 849-1990

New York Office

595 Madison Avenue, 26th Floor
New York, NY 10022
Phone (212) 223-7400